AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21566232
Drug: NeuroFlo treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NeuroFlo treatment
Trial: 26539650
Drug: rosuvastatin 10
RxNorm normalized name: rosuvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 10 mg
Trial: 20361676
Drug: Oral sodium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sodium iron edetate (SIE)
Trial: 23771193
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg single dose in postbariatric surgery group
Trial: 2203486
Drug: Oral RO
RxNorm normalized name: ALCOHOL 70 mL in 100 mL TOPICAL GEL [Floral rose scented hand sanitizer 01]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral RO 42-5892 (600 mg)
Trial: 2110787
Drug: Intramuscular lorazepam
RxNorm normalized name: Lorazepam
DrugBank: Lorazepam (DB00186)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular lorazepam
Trial: 17565435
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg melatonin
Trial: 7978533
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of H1 and H2 histamine antagonists and a corticosteroid in gelatin capsules
Trial: 7978533
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (premedication)
Trial: 29802636
Drug: Basal-bolus therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal-bolus therapy
Trial: 1623908
Drug: Clonidine 200
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine 200 micrograms orally + naloxone i.v. (2.8 mg/5 h)
Trial: 12814448
Drug: Levosimendan administered
RxNorm normalized name: levosimendan
DrugBank: Levosimendan (DB00922)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levosimendan administered by intravenous infusion
Trial: 18028044
Drug: Fentanyl iontophoretic
RxNorm normalized name: fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl iontophoretic transdermal system (ITS) (40 microg fentanyl/dose)
Trial: 12013151
Drug: Chondroitin sulfate
RxNorm normalized name: Chondroitin Sulfate
DrugBank: Chondroitin sulfate (DB09301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroitin sulfate 800 mg/day plus naproxen 500 mg/day
Trial: 1677267
Drug: Topical bunazosin
RxNorm normalized name: bunazosin
DrugBank: Bunazosin (DB12230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical bunazosin 0.3%
Trial: 9926031
Drug: Psychological treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychological treatments
Trial: 19335074
Drug: 0.3 mg/ml
RxNorm normalized name: menthol 0.3 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/ml rhPDGF‐BB + beta‐TCP + bioabsorbable collagen wound‐healing dressing
Trial: 9923576
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive formulation containing 0.125 mg levonorgestrel and 0.03 mg ethinylestradiol (group B)
Trial: 20389106
Drug: High-fat meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-fat meal (fat content: 38 g, energy content: 640 kcal)
Trial: 3770273
Drug: Intravenous calcium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous calcium infusion (calcium gluconate 36.3 mEq/5 h)
Trial: 6851564
Drug: ONO 802
RxNorm normalized name: ONO-2952
DrugBank: ONO-2952 (DB14802)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO 802 pessaries (1 mg of 16, 16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester)
Trial: 31064405
Drug: Enoxaparin 20
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 20 mg
Trial: 28229275
Drug: Active Treatment
RxNorm normalized name: Active
DrugBank: Octisalate (DB11062)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Active Treatment Group (prebiotic vaginal moisturizer)
Trial: 2316795
Drug: Government Pharmaceutical
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Government Pharmaceutical Organization of Thailand antivenom (mostly F(ab)2 fragments)
Trial: 9702644
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone therapy (0.2 U/kg subcutaneously daily for 28 days)
Trial: 29284596
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy
Trial: 23963102
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg/day
Trial: 3326678
Drug: Meclofenamate sodium
RxNorm normalized name: Meclofenamate Sodium
DrugBank: Meclofenamic acid (DB00939)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Meclofenamate sodium 100 mg
Trial: 20350344
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (FO) supplemented parenteral nutrition (PN)
Trial: 28340570
Drug: Vacc-C5 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vacc-C5 vaccine administered intramuscularly with Alhydrogel or intradermally with GM-CSF as adjuvant
Trial: 28340570
Drug: Vacc-C5 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vacc-C5 vaccine
Trial: 23058047
Drug: Halofantrine (HF)
DrugBank: Halofantrine (DB01218)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Halofantrine (HF) 72 mg/kg (8 mg/kg every 6 to 10 h for 3 days)
Trial: 23058047
Drug: Healthy volunteers
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healthy volunteers (HF doses of 250, 500, and 1000 mg)
Trial: 16253965
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist administration
Trial: 11605932
Drug: Combined spinal-epidural
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined spinal-epidural analgesia (10 microg intrathecal sufentanil with or without 2.0 mg bupivacaine, n = 1,071)
Trial: 11605932
Drug: Epidural analgesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural analgesia (10 microg epidural sufentanil and 12.5-25.0 mg bupivacaine, n = 1,112)
Trial: 23708326
Drug: BCAA treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCAA treatment
Trial: 17319037
Drug: Topical clobetasol
RxNorm normalized name: clobetasol Topical Foam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical clobetasol propionate 0.05% cream
Trial: 22234244
Drug: Intravitreal bevacizumab
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravitreal bevacizumab (IVB) 1.25 mg
Trial: 26829251
Drug: Nifedipine monotherapy
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine monotherapy
Trial: 8473427
Drug: Long treatment
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long treatment protocol (buserelin administered from mid-luteal phase)
Trial: 12953327
Drug: Transdermal patches
RxNorm normalized name: MENTHOL 0.3 g in 100 TOPICAL PATCH [Aroamas Cot Nicotine Transdermal Patches]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal patches releasing estradiol (E2) and progestogen for HRT
Trial: 12385443
Drug: 125 mg
RxNorm normalized name: niacin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg SP-303
Trial: 16121513
Drug: KanJang oral
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: KanJang oral solution (fixed combination of Echinacea purpurea, Adhatoda vasica, and Eleutherococcus senticosus)
Trial: 9681586
Drug: Flunitrazepam 2
RxNorm normalized name: flunitrazepam 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunitrazepam 2 mg (FNZ2N)
Trial: 22418764
Drug: Low concentration
RxNorm normalized name: Dianeal Low Calcium 1.5 Intraperitoneal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low concentration of heparin (LCH) 2,500 IU/ml
Trial: 11281052
Drug: Granulocyte Colony-Stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte Colony-Stimulating Factor (rhG-CSF) 5 micrograms/kg/day subcutaneous as a supplement to antibiotherapy
Trial: 22753019
Drug: Colchicine 0.6
RxNorm normalized name: colchicine 0.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine 0.6 mg single dose in young subjects
Trial: 9657564
Drug: Specific immunotherapy
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific immunotherapy
Trial: 17409368
Drug: Physician defying
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Physician defying DSS recommendation with less aggressive treatment
Trial: 17409368
Drug: Physician defying
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Physician defying DSS recommendation with more aggressive treatment
Trial: 16100184
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone dipropionate (BDP) at doses > 100 microg
Trial: 11517852
Drug: Placentrex treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placentrex treatment
Trial: 27291249
Drug: Grazoprevir 100
RxNorm normalized name: grazoprevir 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grazoprevir 100 mg once daily and Ribavirin for 24 weeks
Trial: 9663357
Drug: Irbesartan 300
RxNorm normalized name: irbesartan 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan 300 mg once daily (after dose doubling if SeDBP >= 90 mm Hg)
Trial: 27804233
Drug: Irbesartan treatment
RxNorm normalized name: Irbesartan
DrugBank: Irbesartan (DB01029)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Irbesartan treatment
Trial: 31035117
Drug: Vaginal progesterone
RxNorm normalized name: progesterone Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal progesterone gel
Trial: 12377810
Drug: Hypnotic relaxation
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic relaxation
Trial: 28678148
Drug: Levosimendan (No-L-group)
RxNorm normalized name: levosimendan
DrugBank: Levosimendan (DB00922)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levosimendan (No-L-group)
Trial: 16255132
Drug: Bevacizumab (Avastin)
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab (Avastin) as a component of first-line treatment
Trial: 16255132
Drug: Cetuximab (Erbitux)
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Cetuximab (Erbitux) in standard first-line chemotherapy
Trial: 15963077
Drug: Rifaximin 600
RxNorm normalized name: Rifaximin
DrugBank: Rifaximin (DB01220)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rifaximin 600 mg/day
Trial: 10741936
Drug: Rifaximin 2400
RxNorm normalized name: Rifaximin
DrugBank: Rifaximin (DB01220)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rifaximin 2400 mg/day
Trial: 15592697
Drug: Low-dose-rate (LDR)
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose-rate (LDR) brachytherapy
Trial: 30054636
Drug: Positive CTC
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive CTC assay result in hormone receptor-negative disease
Trial: 21316048
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) 50 mg/d
Trial: 1982108
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg nizatidine BID
Trial: 2269924
Drug: Silver sulfadiazine
RxNorm normalized name: Silver Sulfadiazine
DrugBank: Silver sulfadiazine (DB05245)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silver sulfadiazine and hydrocortisone cream 1% (used in combination)
Trial: 6102442
Drug: Chlorpheniramine maleate
RxNorm normalized name: Chlorpheniramine Maleate
DrugBank: Chlorpheniramine (DB01114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpheniramine maleate 4 mg tid
Trial: 30764805
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D therapy (800 IU cholecalciferol daily)
Trial: 8489569
Drug: Diclofenac-sucralfate association
RxNorm normalized name: Sucralfate
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diclofenac-sucralfate association (50 mg)
Trial: 8489569
Drug: Enteric-coated tablets
RxNorm normalized name: lipase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteric-coated tablets (50 mg)
Trial: 31615934
Drug: EUS examination
RxNorm normalized name: chlorine dioxide
DrugBank: Chlorine dioxide (DB12453)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EUS examination after 3-5 mL submucosal saline injection (SSI)
Trial: 19394618
Drug: Atorvastatin 80mg
RxNorm normalized name: AMLODIPINE 5MG/ATORVASTATIN 80MG TAB
DrugBank: Atorvastatin (DB01076)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atorvastatin 80mg daily
Trial: 19875309
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of ramipril until the morning of surgery and vasopressin infusion (Group C)
Trial: 29110696
Drug: Topical tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical tranexamic acid (TXA)
Trial: 31480553
Drug: Caffeine supplement
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine supplement (CAF; 6 mg∙kg‐1)
Trial: 30219920
Drug: GH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH treatment
Trial: 10793878
Drug: E2 1
RxNorm normalized name: PGE2 10 MG Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2 1 mg/NETA 0.25 mg
Trial: 3497990
Drug: PRP-D vaccine
RxNorm normalized name: Hib (PRP-D)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP-D vaccine
Trial: 3549393
Drug: Booster dose
RxNorm normalized name: SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 50 MCG/0.5 ML Intramuscular Suspension [MODERNA COVID-19 VACCINE BOOSTER DOSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster dose of PRP-D
Trial: 22796139
Drug: VAX128 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VAX128 vaccine (various constructs)
Trial: 12571693
Drug: Administration of
RxNorm normalized name: IV solutions used in parenteral administration of fluids, electrolytes and nutrients
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Administration of beta-blockers
Trial: 30795705
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 250 µg twice daily (BD)
Trial: 15312254
Drug: Pravastatin and
RxNorm normalized name: pravastatin and ezetimibe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin and nonstatin cholesterol-lowering drugs
Trial: 31658542
Drug: Silver sulfadiazine
RxNorm normalized name: Silver Sulfadiazine
DrugBank: Silver sulfadiazine (DB05245)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silver sulfadiazine cream with dressing change every other day
Trial: 26888240
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of semilunar coronally advanced flap (SCAF) and button technique
Trial: 27743432
Drug: Multispecies probiotic
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multispecies probiotic supplements
Trial: 2403123
Drug: Bicarbonate infusion
RxNorm normalized name: Potassium Bicarbonate
DrugBank: Potassium bicarbonate (DB11098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicarbonate infusion (1.3%)
Trial: 28234053
Drug: BI 671800
RxNorm normalized name: BI-671800
DrugBank: BI-671800 (DB12524)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BI 671800 400 mg P.M. with fluticasone propionate
Trial: 22987572
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg rosuvastatin
Trial: 16322140
Drug: Multisystemic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multisystemic therapy (MST)
Trial: 31462933
Drug: Both drugs
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both drugs
Trial: 30587955
Drug: O2matic-controlled treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: O2matic-controlled treatment
Trial: 17224017
Drug: Audio-tape with
RxNorm normalized name: E-Z Scrub with Ultradex Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Audio-tape with relevant information regarding implant insertion
Trial: 21687997
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of MG and SOL
Trial: 31843975
Drug: C1 esterase
RxNorm normalized name: C1 esterase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C1 esterase inhibitor 50 U/kg
Trial: 7197583
Drug: Cisplatin 90
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin 90 mg/m2 every 3 weeks
Trial: 20974320
Drug: Midazolam 50
RxNorm normalized name: midazolam 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 50 µg/kg IV
Trial: 20974320
Drug: Midazolam 75
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam 75 µg/kg IV
Trial: 10381787
Drug: 15 mg/day
RxNorm normalized name: Climara Pro 0.045/0.015 MG/Day Weekly Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/day meloxicam
Trial: 7536380
Drug: Digital rectal
RxNorm normalized name: BD Thermometer Digital Rectal (obsolete)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digital rectal examination 24 hours before the second PSA determination
Trial: 1699653
Drug: CHOP +
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CHOP + low-dose bleomycin
Trial: 1341478
Drug: Interferon alone
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alone therapy
Trial: 29140808
Drug: AGE with
RxNorm normalized name: zinc bandage with supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AGE with supplements (AGE+S)
Trial: 16540840
Drug: Caffeinated drink
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeinated drink (5 mg x kg(‐1))
Trial: 20880169
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of oral revaprazan daily for 7 days
Trial: 6754384
Drug: Betamethasone 9
RxNorm normalized name: Betamethasone
DrugBank: Betamethasone phosphate (DB14669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone 9 mg (Celeston Chronodose)
Trial: 19036671
Drug: Tigecycline 100
RxNorm normalized name: Tigecycline
DrugBank: Tigecycline (DB00560)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tigecycline 100 mg/day (100 mg initial dose, then 50 mg intravenously twice daily)
Trial: 16251309
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of vancomycin 2 g/day (1 g intravenously twice daily) and aztreonam 4 g/day (2 g intravenously twice daily)
Trial: 11503006
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg
Trial: 7358867
Drug: Parenteral Nefopam
RxNorm normalized name: nefopam
DrugBank: Nefopam (DB12293)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral Nefopam
Trial: 2619149
Drug: Ketorolac solution
RxNorm normalized name: ketorolac Injectable Solution
DrugBank: Ketorolac (DB00465)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketorolac solution 0.5% eye drops
Trial: 29798375
Drug: Intratympanic dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intratympanic dexamethasone (10 mg/ml)